Altimmune Inc (ALT)
6.79
+0.05
(+0.74%)
USD |
NASDAQ |
Nov 04, 16:00
6.71
-0.08
(-1.18%)
After-Hours: 06:33
Altimmune Net Income (Annual): -88.45M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -88.45M |
| December 31, 2022 | -84.71M |
| December 31, 2021 | -97.09M |
| December 31, 2020 | -49.04M |
| December 31, 2019 | -20.52M |
| December 31, 2018 | -39.17M |
| December 31, 2017 | -46.43M |
| December 31, 2016 | -11.09M |
| December 31, 2015 | -3.441M |
| December 31, 2014 | -9.955M |
| Date | Value |
|---|---|
| December 31, 2013 | -11.72M |
| December 31, 2012 | -4.920M |
| December 31, 2011 | -3.798M |
| December 31, 2010 | -34.85M |
| December 31, 2009 | -32.28M |
| December 31, 2008 | -36.42M |
| December 31, 2007 | -13.59M |
| December 31, 2006 | -15.13M |
| December 31, 2005 | 0.2773M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-97.09M
Minimum
2021
-20.52M
Maximum
2019
-67.96M
Average
-84.71M
Median
2022
Net Income (Annual) Benchmarks
| Eli Lilly and Co | 5.240B |
| Viking Therapeutics Inc | -85.90M |
| Amgen Inc | 6.717B |
| Avid Bioservices Inc | -140.75M |
| NovaBay Pharmaceuticals Inc | -9.64M |